All Articles

Genomics leader IDT launches its first IVD-grade NGS tests for cancer, aiming to standardize diagnostics and accelerate precision medicine.

With a new grant, Tessera Therapeutics is advancing its novel Gene Writing platform to engineer a scalable, single-shot cure for HIV. But can it work?

With the appointment of Ben Wright as CRO, Insight Assurance signals a major push for global growth, leveraging AI to tackle complex cybersecurity regulations.

The L.A.-based bank extends its $300M stock repurchase program and will redeem $385M in notes, a move analysts see as a confident financial play.

Facing financial headwinds, Cyber Enviro-Tech signs a major deal to bring compressed air power to emerging markets. But can the technology and the company deliver?

Autonomous driving firm WeRide posts record 2025 revenue and narrows losses, fueled by aggressive international expansion and key driverless permits.

A new partnership aims to end token fraud by embedding issuer identity directly into digital assets, bridging the gap between traditional and on-chain finance.

A new one-hour test for sepsis could change critical care, offering rapid results that help doctors fight the clock and save lives. Here's how it works.

Public Policy Holding Company's latest UK acquisition signals a major shift, making data-driven economic analysis a core weapon in corporate lobbying.

Private equity firm OEP takes UK food distributor Kitwave private, signaling a major M&A push in Britain's fragmented wholesale supply chain.

With a new $1 billion war chest from J.P. Morgan and Morgan Stanley, Core Scientific is racing to convert its crypto mines into AI data centers.

Q2 Metals reports stunning 200+ meter lithium intercepts in Quebec but delays its resource estimate, betting that bigger is better for the EV market.

Alithya's latest research shows firms are moving past AI hype, focusing on data foundations and measurable ROI across finance, manufacturing, and healthcare.

A $10M investment by ATCO kickstarts a $1B Arctic port and road, a project poised to unlock resources, assert sovereignty, and reshape Canada's North.

With major expansions in the US and Europe, Cambrex aims to lead the high-stakes race for specialized API production, targeting next-generation therapies.

Diageo's YunTuo distillery sweeps top honors, proving that Chinese-origin single malt is ready for the world stage. A new chapter in whisky begins.

A major labor dispute at the world's top drug manufacturer threatens global supply chains, with a union pointing to deep-seated governance issues at Samsung.

Interna Therapeutics, Oxford, and the Gates Foundation team up on a novel intranasal siRNA spray to prevent COVID, tested in a human challenge trial.

35,000 runners raced through China's World Heritage sites in a marathon blending ancient history with AI management and a massive economic boom for the city.

The five-year, 1.5 MTPA agreement highlights the critical role of U.S. LNG for energy security as a major supply disruption roils the global market.